North America holds a significant share of the DNA microarray chips market, driven by increasing research and development activities, widespread adoption of molecular diagnostics, and growing demand for genomic testing. The region benefits from well-established healthcare infrastructure, favorable funding for biotechnology research, and continuous technological advancements in genomic analysis...

The US DNA microarray chips market is witnessing strong growth due to increasing investments in genomic research, precision medicine, and molecular diagnostics. The presence of leading biotechnology companies, advanced healthcare infrastructure, and extensive government support for genomics initiatives is driving the adoption of DNA microarray technologies. Growing demand for personalized...